The SIAPS Namibia Project Director, Dr. Evans Sagwa, has advocated for adoption of strategies to ensure drug safety in TB and HIV treatment programs in the country. He made this call while delivering a public lecture on Friday, September 22, 2017, entitled “Strategies for optimizing patient safety in HIV and TB treatment programs in Namibia,” […]
Pediatric Antiretroviral Treatment Uptake, Treatment Adherence, Regimen Switches, and Retention in Care in Namibia
In Namibia, a preliminary review of EDT records suggests that children form a small proportion of the patients accessing ART in any given setting, nationally composing 8% of the patients on ART in the MoHSS facilities. Over the years, managing children has been complicated with formulations that have not been friendly for children, complicated regimens, and occasional stock-outs of pediatric ARVs. These challenges may increase the number of children that might receive suboptimal care, including delayed or no interventions in face of poor adherence, ultimately leading to suboptimal response to treatment. This can then increase the risk of HIV drug resistance and leads to short survival of HIV-infected children. Findings from this assessment will provide much needed evidence on trends in pediatric HIV treatment uptake, levels of adherence, and retention among those on treatment. Ultimately, the evidence generated will support MoHSS policy makers and leaders in modifying and strengthening interventions aimed at enhancing treatment uptake, adherence, retention, and viral load suppression among HIV-infected children in Namibia.
A Q&A with Greatjoy Mazibuko, SIAPS Senior Technical Manager in Namibia You’re working in Namibia, which has one of the highest prevalence rates of HIV in the world. How does this affect life in the country? The prevalence of HIV infection stood at 17.2% in 2016, which is relatively high for sub-Saharan Africa, but it’s […]
SIAPS partners with the University of Namibia to host the third international medicine utilization research symposium
SIAPS provided technical assistance to the University of Namibia-School of Pharmacy (UNAM-SoP) in organizing the third international Medicines Utilisation Research in Africa (MURIA) workshop and symposium in Windhoek, June 26–28, 2017. With the theme of “Medicine utilisation research in Africa, influencing patient care and policy”, the conference highlighted the importance of building the capacity of […]
The U.S. Ambassador to Namibia, H.E. Thomas Daughton, visited a hospital and clinic in the Oshana region of Namibia last week to unveil a new electronic stock card, an innovation that has greatly improved service delivery in the country. The Facility Electronic Stock Card (FESC) simplifies pharmaceutical inventory control tasks, allowing pharmacy staff to devote […]
In a major advance against the spread of HIV, Namibia has approved the use of emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) to prevent HIV infection. The Namibian Medicines Regulatory Council (NMRC) approved a generic version of the medicine, Ricovir EM®, which is manufactured by Mylan Pharmaceuticals. It is used in combination with other antiretroviral medications to treat […]
On June 1, 2017, 38 new pharmacy assistants (PAs) graduated from Namibia’s National Health Training Center (NHTC). At the graduation ceremony, Dr. Andreas Mwoombola, the Permanent Secretary of the Ministry of Health and Social Services (MOHSS), encouraged the graduates to prioritize the health of their communities and to serve those communities with dignity. He decried […]
Patients on lifelong antiretroviral therapy (ART) may be at risk of forgetting their pharmacy appointments for antiretroviral (ARV) refills. The SMS-based ART pharmacy appointment and medication adherence reminder service provides automated text notifications to ART patients reminding them to pick up their ARV refills according to appointment dates made by pharmacy staff using the SIAPS-supported Electronic Dispensing Tool (EDT). The service was introduced in May 2015 at 10 public-sector ART sites in 6 of Namibia’s 14 regions.
Consolidating SIAPS’ Five-Year Support to the Ministry of Health and Social Services for Strengthening Pharmacovigilance in Namibia
The goal of SIAPS in Namibia was to improve the quality and safety of pharmaceutical services to achieve sustained HIV epidemic control. Since 2012, SIAPS focused on interventions that increased the availability of quality antiretrovirals (ARVs), other essential medicines, and services to sustain more than 80% ART coverage of patients in need. SIAPS activities also contributed to ensuring patient safety through pharmacovigilance (PV) activities.
SIAPS recently transferred office equipment and household items—which the program had acquired during the previous USAID-funded Strengthening Pharmaceutical Systems project, also implemented by MSH—to the Christian Family Centre (CFC) in Windhoek. The CFC is involved in ministry, education, and support to homeless Namibians. The USAID mission in Namibia selected it as a recipient of the […]
A comprehensive assessment of DPM’s medicine regulatory system was conducted September to October 2017 by SIAPS funded by USAID. The […]
A presentation by Kwesi Eghan, Principal Technical Advisor, on March 19, 2018.
According to the World Health Organization, many countries spend 30–40% of their health care budgets on medicines and medical commodities, […]